Vaishali Pharma states that consolidated results are being prepared from the date of associate acquisition in Kesar Pharma and that earlier period comparatives are not provided due to the new consolidation. This clarification explains the absence of prior consolidated figures and the standalone balance sheet presentation for the 30 September 2025 period.